SCHEMBL6527262

SCHEMBL6527262

Cc1cc(-c2ccc(OC3CN(Cc4ccc(C(C)C)cc4)C3)cc2)ccc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
S1PR5 Q9H228 7/20 0.44
S1PR1 P21453 6/20 0.44
KCNH2 Q12809 2/20 0.44
MCHR1 Q99705 2/20 0.44
HRH3 Q9Y5N1 1/20 0.42
RARB P10826 1/20 0.42
BCHE P06276 2/20 0.41
MAOB P27338 1/20 0.41
ADRB1 P08588 2/20 0.41
ADRB3 P13945 2/20 0.41
PRKAB2 O43741 1/20 0.39
PRKAG1 P54619 1/20 0.39
PRKAA2 P54646 1/20 0.39
PRKAA1 Q13131 1/20 0.39
PRKAG3 Q9UGI9 1/20 0.39
PRKAG2 Q9UGJ0 1/20 0.39
PRKAB1 Q9Y478 1/20 0.39
PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3660641 0.87 MEN1 (0.57) MEN1KMT2AS1PR5S1PR1KCNH2
SCHEMBL12788189 0.86 MEN1 (0.44) MEN1KMT2AS1PR5S1PR1KCNH2
SCHEMBL6522775 0.82 MEN1 (0.56) MEN1KMT2AS1PR5S1PR1KCNH2
SCHEMBL3659215 0.82 MEN1 (0.53) MEN1KMT2AS1PR5S1PR1KCNH2
SCHEMBL6523290 0.79 MEN1 (0.52) MEN1KMT2AKCNH2MCHR1HRH3
SCHEMBL6521805 0.79 KMT2A (0.78) MEN1KMT2AKCNH2MCHR1HRH3
SCHEMBL12788185 0.77 MEN1 (0.51) MEN1KMT2AKCNH2MCHR1HRH3
SCHEMBL12788206 0.77 KMT2A (0.51) MEN1KMT2AKCNH2MCHR1HRH3
SCHEMBL12788205 0.77 MEN1 (0.50) MEN1KMT2AS1PR5S1PR1KCNH2
SCHEMBL3659855 0.74 STAT3 (0.45) S1PR5S1PR1PRKAA2RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists GPR119, GIPR, GPR39 MEN1 2395/4885KMT2A 3734/4885S1PR5 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.